Trial Outcomes & Findings for Fluorine F 18 EF5 PET/CT Imaging in Patients With Locally Advanced or Recurrent/Metastatic Cervical Cancer (NCT NCT00978874)
NCT ID: NCT00978874
Last Updated: 2021-06-25
Results Overview
The study was terminated and no data are available to be reported
Recruitment status
TERMINATED
Study phase
NA
Target enrollment
15 participants
Primary outcome timeframe
7 years
Results posted on
2021-06-25
Participant Flow
Participant milestones
| Measure |
All Subjects
fludeoxyglucose F 18
fluorine F 18 EF5
|
|---|---|
|
Overall Study
STARTED
|
0
|
|
Overall Study
COMPLETED
|
0
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Fluorine F 18 EF5 PET/CT Imaging in Patients With Locally Advanced or Recurrent/Metastatic Cervical Cancer
Baseline characteristics by cohort
Baseline data not reported
PRIMARY outcome
Timeframe: 7 yearsPopulation: The study was terminated and no data are available to be reported
The study was terminated and no data are available to be reported
Outcome measures
Outcome data not reported
Adverse Events
All Subjects
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place